This study, called the Embryo Health Study, is looking at how patients feel about getting extra information about the risk of polygenic disorders (diseases caused by multiple genes) in their embryos. If you are undergoing in vitro fertilization (IVF) and already plan to have Preimplantation Genetic Testing for Aneuploidies (PGT-A), which checks embryos for chromosome abnormalities, you might be able to join. The study will offer you the option to also get information on your embryos' risk for certain polygenic diseases like Type 1 Diabetes or Breast Cancer, after receiving genetic counseling. The main goal is to understand patients' interest in this additional testing. This is an observational study, meaning researchers will gather information without giving new treatments, and it aims to include 500 participants. The current status of the study is unclear.

Study design

This is an observational study that plans to enroll 500 participants. It is not specified if it is randomized, blinded, or what phase it is in.

What's involved

If you join, you will receive genetic counseling to discuss PGT-A and PGT-P (Preimplantation Genetic Testing for Polygenic Disorders) and provide saliva samples. You will then receive reports on your embryos.

Compensation

Not stated in the trial record.

Follow-up

Your interest in Preimplantation Genetic Testing for Polygenic Disorders will be measured at 2 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.